Natural Cycles Gets FDA Clearance for AI Fertility Algorithm
Natural Cycles has received its sixth FDA clearance for its next generation AI powered NC° Fertility Algorithm, the company announced in a press release.
The updated algorithm combines statistical modeling with machine learning trained on tens of millions of fertility data points. It is designed to adapt to individual cycle patterns and provide more individualized fertility predictions.
The company said evidence submitted to the FDA showed the algorithm maintained its established safety and effectiveness rates. Natural Cycles also said the update gives many users more Green Days, when the app confirms pregnancy protection is not needed.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Novo Nordisk Partners With Anthropic on Drug Research
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
CureMD Earns ISO/IEC 42001 Certification for AI Management
Theranica AI Predicts Next Day Migraine Risk With 91.2% Precision
Natura Introduces $99 Interface Ring for AI Agents
Daily AI Brief: the AI news that matters, in your inbox.